Display options
Share it on

Niger Med J. 2013 Nov;54(6):426-9. doi: 10.4103/0300-1652.126302.

Serum alpha-fetoprotein level is higher in hepatitis C than hepatitis B infected chronic liver disease patients.

Nigerian medical journal : journal of the Nigeria Medical Association

Mathias Abiodun Emokpae, Babatunde Gabriel Adejumol, Aliyu Abdu, Nasiru Magaji Sadiq

Affiliations

  1. Department of Medical Laboratory Science, School of Basic Medical Sciences, College of Medical Sciences, University of Benin, Benin City, Kano, Nigeria ; Department of Chemical Pathology Aminu Kano Teaching Hospital, Kano, Nigeria.
  2. Department of Medical Laboratory Science, School of Basic Medical Sciences, College of Medical Sciences, University of Benin, Benin City, Kano, Nigeria.
  3. Department of Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria.
  4. Department of Medical Microbiology Aminu Kano Teaching Hospital, Kano, Nigeria.

PMID: 24665160 PMCID: PMC3948968 DOI: 10.4103/0300-1652.126302

Abstract

BACKGROUND: The frequency of raised serum alpha-fetoprotein may vary in relation to hepatitis B or C infection in chronic liver disease (CLD). The study evaluated the frequency of hepatitis B and C in patients with chronic liver disease and correlated the levels of serum alpha-fetoprotein with hepatitis B and C infection in the patients.

MATERIALS AND METHODS: Eighty-six patients with CLD were recruited for the study. Fifty subjects, with no CLD were used as control. Hepatitis B surface Antigen (HBsAg) and hepatitis C antibody were determined using enzyme-linked immunosorbent assay (ELISA) technique (Human diagnostics, Germany and HCV Murex 40 Anhet laboratories, USA) while liver function tests were evaluated using express plus chemistry auto analyzer. Alpha-fetoprotein was assayed using ELECSYS 1010 auto analyser.

RESULTS: There were 60 males and 26 females, with a mean age of 46 + 6.5 years, while the controls were 25 males and 25 females with a mean age of 41 ± 2.5 years. Thirty-six subjects (41.7%) were seropositive for HBsAg while 24 (27.9%) were seropositive for Hepatitis C Virus (HCV) antibody. The mean alpha fetoprotein level was 359 ± 9.9 ng/mL while mean control value was 1.93 ± 0.24 ng/mL. Liver function test parameters were elevated compared with control subjects (P < 0.001). The increase in serum alpha-fetoprotein was higher (P < 0.001) in HCV than HBsAg positive patients.

CONCLUSION: Serum alpha-fetoprotein level was highest in HCV compared to HBsAg positive and hepatitis negative patients with CLD.

Keywords: Alpha fetoprotein; HBsAg; HCV antibody; chronic liver disease

References

  1. Mod Pathol. 2010 Feb;23(2):276-83 - PubMed
  2. J Hepatol. 1998 Jan;28(1):27-33 - PubMed
  3. Indian J Med Microbiol. 2004 Oct-Dec;22(4):269-70 - PubMed
  4. Am J Trop Med Hyg. 1993 Apr;48(4):581-4 - PubMed
  5. J Ayub Med Coll Abbottabad. 2003 Jul-Sep;15(3):54-5 - PubMed
  6. Hepatology. 1995 Oct;22(4 Pt 1):1101-8 - PubMed
  7. Am J Prev Med. 1994;10 Suppl:45-55 - PubMed
  8. Br J Cancer. 1994 Jun;69(6):1157-9 - PubMed
  9. Epidemiol Infect. 1996 Oct;117(2):327-32 - PubMed
  10. Trans R Soc Trop Med Hyg. 1995 Mar-Apr;89(2):171-4 - PubMed
  11. J Hepatol. 1998 Apr;28(4):608-14 - PubMed
  12. Indian J Med Microbiol. 2005 Oct;23(4):273-4 - PubMed
  13. PLoS One. 2008 Jun 11;3(6):e2391 - PubMed
  14. PLoS One. 2012;7(7):e39466 - PubMed
  15. Hepatology. 1990 Dec;12(6):1420-32 - PubMed
  16. Trans R Soc Trop Med Hyg. 1997 Jan-Feb;91(1):38-41 - PubMed
  17. Ann Intern Med. 2006 May 16;144(10):705-14 - PubMed
  18. J Hepatol. 1994 Aug;21(2):159-66 - PubMed
  19. West Afr J Med. 1997 Oct-Dec;16(4):198-203 - PubMed

Publication Types